Skip to main content
Log in

Biphasic Testosterone Delivery Profile Observed with Two Different Transdermal Formulations

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Our long-term goal is to develop formulations for pulsatile testosterone (T) delivery. T has been reported earlier to show biphasic pharmacokinetics in humans by Mazer et al, as well as biphasic permeation across excised rat skin by our group. We examined two kinds of formulations to evaluate their delivery profiles and to assess whether differences in the formulation approach affect pharmacokinetics in animal models.

Methods. One formulation consisted of T and a polymer blend dissolved in isopropanol; administered by dispensing the solution on the skin to cast a film in situ. The other was an adhesive-dispersion patch. In vitro release from the patch was evaluated using a flow-through cell interfaced with an HPLC pump and UV detector. Single dose pharmacokinetics were evaluated in castrated Wistar rats and bonnet monkeys immunized against gonadotropin-releasing hormone to deplete endogenous T.

Results. Two maximas were observed in the T release profile from the patch and in serum concentration versus time profiles in both animal models on application of either formulation. The relative magnitudes of the two maximas and the time interval separating them were different in the case of each formulation.

Conclusions. Both formulations result in biphasic pharmacokinetics of T in the animal models studied. Discrete maximas presumably correlate with 'burst' and 'sustained' phases of drug release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. N. A. Mazer, W. E. Heiber, J. F. Moellmer, A. W. Meikle, J. D. Stringham, S. W. Sanders, K. G. Tolman, and W. D. Odell. J. Control. Rel. 19:347–362 (1992).

    Google Scholar 

  2. J. C. Findlay, V. Place, and P. J. Snyder. J. Clin. Endocrinol. Metab. 68:369–373 (1987).

    Google Scholar 

  3. V. A. Place, L. Atkinson, D. A. Prather, N. Trunnel, and F. E. Yates. In: E. Nieschlag and H. M. Behre (Eds), Testosterone: action, deficiency, substitution. Springer-Verlag Berlin, 1990, pp. 165–181.

    Google Scholar 

  4. A. M. Matsumoto. J. Clin. Endocrinol. Metab. 70:282–287 (1990).

    Google Scholar 

  5. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Lancet 336:955–959 (1990).

    Google Scholar 

  6. G. F. Weinbauer, A. Linberger, H. M. Behre, and E. Nieschlag. J. Endocrinol. 142:485–495 (1994).

    Google Scholar 

  7. F.C.W. Wu, P.L. Taylor, and R.E. Sellar. J. Endocrinol. 123:149–158 (1989).

    Google Scholar 

  8. M. Takiwaka and K. Wakabayashi. Endocrine J. 41:257–265 (1994).

    Google Scholar 

  9. J. S. Finkelstein, R. W. Whitcomb, L. St. L. O'Dea, C. Longcopes, D. A. Schoenfeld, and W. F. Crowley Jr. J. Clin. Endocrinol. Metab. 73:609–620 (1991).

    Google Scholar 

  10. A. Misra, P. Upadhyay, and Om Singh in M. Rajalakshmi (Ed) Male Contraception: Present and Future, New Age Publishers, New Delhi (in press).

  11. A. Misra, R. S. Raghuvanshi, S. Ganga, M. Diwan, G. P. Talwar, and Om Singh. J. Control Rel. 39:1–7 (1996).

    Google Scholar 

  12. A. Misra and P. Upadhyay. Int. J. Pharm. 132:267–270 (1996).

    Google Scholar 

  13. S. B. Sufi, A. Donaldson, and S. L. Jeffcoate. WHO Matched Reagents Programme Methods Manual, 18th Edition, World Health Organization, Geneva, 1994, pp. 74–84.

    Google Scholar 

  14. R. Jayashankar, M. K. Chaudhuri, Om Singh, A. Alam, and G. P. Talwar. Prostate 14:3–11 (1989).

    Google Scholar 

  15. G. R. Merriam. In: W. F. Crowley Jr. and J. G. Hofler (eds). The Episodic Secretion of Hormones, John Wiley and Sons, New York, 1987, pp. 47–66.

    Google Scholar 

  16. M. Katz, V. De Santis, C. Vullo, B. Wonke, H. H. McGarrigle, and B. Bagni, J. Clin. Pathol. 46:660–664 (1993).

    Google Scholar 

  17. G. Schaison, K. Nahoul, and B. Couzinet, In E. Nieschlag and H. M. Behre (eds.), Testosterone: Action, Deficiency, Substitution, Springer-Verlag Berlin, 1990, pp. 155–164.

    Google Scholar 

  18. W. McCabe and J. C. Smith. Unit Operations of Chemical Engineering, 3rd Edition, McGraw-Hill, New York, 1976, pp. 865–875.

    Google Scholar 

  19. H. Sekikawa, M. Nakano, and T. Arita. Chem Pharm Bull 26:118–126 (1978).

    Google Scholar 

  20. M. Yoshioka, B. C. Hancock, and G. Zografi. J. Pharm. Sci. 84:983–986 (1995).

    Google Scholar 

  21. R. T. Kurnik and R. O. Potts, Proc Intern Symp Bioact Mater 23:121–123 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amit Misra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Misra, A., Pal, R., Majumdar, S.S. et al. Biphasic Testosterone Delivery Profile Observed with Two Different Transdermal Formulations. Pharm Res 14, 1264–1268 (1997). https://doi.org/10.1023/A:1012179529090

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012179529090

Navigation